Trials / Completed
CompletedNCT00254709
Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant Recipients
Open, Pilot, Comparative Study to Evaluate the Efficacy and Safety of Two Immunosuppressor Regimens, Anti Il-2, Sirolimus Mycophenolate, Mophetyl and Steroids Versus Sirolimus, Cyclosporine, and Withdrawal of Cyclosporine Since the Third Month and Steroids in Elderly Population
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test two different sirolimus-based immunosuppressive regimens for elderly kidney transplant recipients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sirolimus |
Timeline
- Start date
- 2002-10-01
- Completion
- 2005-09-01
- First posted
- 2005-11-16
- Last updated
- 2012-01-31
Source: ClinicalTrials.gov record NCT00254709. Inclusion in this directory is not an endorsement.